by Ashley Umlauf | Oct 16, 2020 | Clinical, Molecular, SARS-CoV-2
For a highly infectious virus like SARS-CoV-2, an inactivated whole virus control is the gold standard for accuracy. For labs that opt for other control formats, synthetic RNA controls can provide many of the same qualities as inactivated whole virus controls. While...
by Jenny Rowan | Oct 8, 2020 | Clinical, Molecular, SARS-CoV-2
The COVID-19 pandemic has put increasing pressure on front-line healthcare workers to deliver fast and accurate test results. For any clinical diagnostic testing, laboratory professionals need assurance that sample preparation methods, as well as the instrumentation...
by Amanda Yasgar | Aug 13, 2020 | Clinical, Molecular, SARS-CoV-2
I think by now it is safe to say that we are truly living in unprecedented times with the current Coronavirus pandemic. The majority of us have never experienced anything even remotely similar to this in our lives before. If you are currently a front-line worker in...
by Microbiologics | May 15, 2020 | Molecular, SARS-CoV-2
By Marylou Gibson, Ph.D Adapted from a post that originally appeared on LinkedIn. Of the more than 55 RT-PCR Test kits or assays currently available under Emergency Use Authorizations (EUA) by the FDA, few target the same genes. Many more similar PCR based tests are...
by microbiologics | May 8, 2020 | Molecular
By Marylou G. Gibson, Ph.D Adapted from a post that originally appeared on LinkedIn. Positive controls are the gold standard in every experiment; we learned that in high school lab. A positive control sample included in your test shows you and your client that the...
by Joshua Pulido, MHA, MT(ASCP) | Aug 1, 2019 | Clinical, Molecular
Photo Source: Lind, Lancet 1982 Last week we shared the Clinical Case File of a patient with persistent dysuria and asked our readers to determine the cause of the symptom. Here are the poll results: Adenovirus (4%, 7 Votes) Herpes simplex virus (9%, 21 Votes) Human...
